QIAGEN Introduces NeuMoDx HIV-1 Quant Assay in Thailand for Blood-Borne Virus Testing

QIAGEN has announced the approval of its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay for use in Thailand. This approval completes the suite o...

April 15, 2024 | Monday | News
President Smt Droupadi Murmu Introduces India's Historic Breakthrough in Cancer Treatment: Launches Groundbreaking Gene Therapy at IIT Bombay

India marked a historic milestone in its fight against cancer as President Smt Droupadi Murmu inaugurated the nation's inaugural homegrown ...

April 05, 2024 | Friday | News
Innovent Biologics and HUTCHMED Announce Priority Review for Novel Combination Therapy in Advanced Endometrial Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

April 02, 2024 | Tuesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
China Medical University Hospital (CMUH) Innovates iDREAM for Home Detection of Sleep Apnea

Snoring can be an alarming sign of obstructive sleep apnea syndrome (OSAS). Studies showed that 50% of individuals who snore may experience sleep apnea, wh...

April 01, 2024 | Monday | News
HUTCHMED's Savolitinib Advances for Expanded Approval in China, Promising New Hope for Lung Cancer Patients

  — If approved, would confirm 2021 conditional approval and expand indication to more patients — HUTCHMED (China) Lim...

March 28, 2024 | Thursday | News
Takeda's ADZYNMA® Receives Approval in Japan for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    cTTP, an ultra-rare blood clotting disorder, presents life-threatening acute events and debilitating chronic symptoms. Untreated acute TTP ...

March 27, 2024 | Wednesday | News
MediciNova Receives Notice of Allowance for MN-166 Patent in Japan

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ:MNOV) and the Tokyo Stock Exchange (Code Number: 4875), has receiv...

March 27, 2024 | Wednesday | News
Biocytogen Partners with ABL Bio to Forge Ahead in Bispecific Antibody-Active Ingredient Conjugate Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotechnology company focused on the development of novel antibody the...

March 26, 2024 | Tuesday | News
Merck Commits Over €300 Million to Establish Cutting-Edge Life Science Production Hub in South Korea

  Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science, emphasized the strategic importance of this move, stating, "The Asia...

March 21, 2024 | Thursday | News
Samsung Ventures Backs BrickBio to Pave the Way for Next-Generation Therapies

Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...

March 19, 2024 | Tuesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Novartis Expands Biopharmaceutical Manufacturing Site in Singapore

The expanded facility will focus on manufacturing therapeutic antibody drugs, contributing to the delivery of breakthrough treatments to patients globally....

March 18, 2024 | Monday | News
Biotech Lobbying Powerhouse BIO Ends Association with WuXi AppTec Amid Security Crackdown

Biotechnology Innovation Organization (BIO), a leading lobbying group in Washington, D.C., announced its decision to sever ties with WuXi AppTec, a Chinese...

March 15, 2024 | Friday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close